Brief: Ani Pharmaceuticals Announces FDA Approval And Launch Of Isosorbide Mononitrate Tablet
08/04/2026 13:10
April 8 (Reuters) - ANI Pharmaceuticals Inc ANIP.O: ANI PHARMACEUTICALS ANNOUNCES FDA APPROVAL AND LAUNCH OF ISOSORBIDE MONONITRATE TABLET Source text: ID:nGNX5hRwsx Further company coverage: ANIP.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on ANI Pharmaceuticals
See all newsBrief: Ani Pharmaceuticals Announces The Launch Of Duloxetine Delayed-Release Capsules
Brief: Ani Pharmaceuticals Announces The FDA Approval Of Everolimus Tablets For Oral Suspension
Brief: Ani Pharmaceuticals Appoints Henry Gosebruch To Board Of Directors
U.S. RESEARCH ROUNDUP-Compass Minerals, Duke Energy, Tesla
ANI Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary